The DOI matches its Crossref record; 30 of the 36 references it cites were found in a registry or an index; none of the 10 sources its claims cite is checked for support yet.
A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder
Open accessAbstract
Background: Acceptance and commitment therapy (ACT) is one of the newest treatment strategies that has been developed rapidly to improve the treatment of patients with obsessive–compulsive disorder (OCD). The aim of this study was to evaluate and compare the effect of ACT and selective serotonin reuptake inhibitors (SSRIs) drugs on the severity of depression symptoms and quality of life (QOL) in obsessive–compulsive patients. Materials and Methods: A randomized clinical trial with a control group was conducted including 27 patients with OCD. Based on the Diagnostic and Statistical Manual of Mental Disorders‑5 criteria for OCD diagnosis, participants were recruited from Tamasha Counseling Center and obsessive–compulsive clinic in the Psychosomatic Research Center in Isfahan, Iran. Selected patients were allocated to two groups (14 in ACT the group and 13 in the drug group with SSRI with a simple random sampling method. ACT group was treated by an ACT therapist in eight 1‑h sessions. Data were collected by the World Health Organization QOL Questionnaire (WHOQOL‑BREF) and Depression subscale of DASS‑42 at admission, after the intervention, and 3 months thereafter. Therapists and evaluators were blind to each other’s work. Data were analyzed using analysis of variance with repeated measures method using IBM SPSS Statistics software (V 23, IBM Corporation, Armonk, NY, USA). Results: Results revealed that both treatments (ACT and SSRIs drug therapy) had significant impacts on reducing depression subscales scores and increasing WHOQOL‑BREF scores at posttreatment (P < 0.05). There were no significant differences in QOL scores between the two groups after the intervention and follow‑up (P > 0.05). Nevertheless, drug therapy presented a significantly greater improvement in depression scores of patients than those resulting from ACT (P = 0.005). The persistence of treatment effects continued after 3 months (follow‑up) in both groups. Conclusion: ACT is equal to SSRIs drug therapy in terms of improving QOL in patients with OCD. However, SSRIs are more effective in treating depression in obsessive–compulsive patients. It may be presumed that ACT without any chemical side effect is equal to drug and is preferred for patients who either cannot use drugs or prefer not to have a drug treatment. © 2022 Journal of Research in Medical Sciences | Published by Wolters Kluwer - Medknow.
Overview
CoChat Summary
## TL;DR
This randomized clinical trial compared group acceptance and commitment therapy (ACT) with SSRI drug treatment for 27–30 patients with obsessive–compulsive disorder (OCD), focusing on quality of life (QOL) and depression. Both treatments improved QOL and reduced depression, but SSRIs produced a greater improvement in depression, while ACT was comparable to SSRIs for QOL.
## Key findings
- In the abstract, both ACT and SSRI therapy had significant effects on reducing depression scores and increasing WHOQOL-BREF scores at posttreatment (`P < 0.05`).
- There were no significant differences in QOL between the two groups after the intervention and at follow-up (`P > 0.05`), and effects persisted after 3 months in both groups.
- Drug therapy showed a significantly greater improvement in depression scores than ACT (`P = 0.005` in the abstract; `P < 0.05` in the results text).
- Group characteristics were similar at baseline: ACT group mean age `32.71 ± 8.27` years and drug group `31 ± 7.43` years; age, sex, marital status, and education status were not significantly different between groups.
## Methods
- Randomized controlled trial with a control group, comparing eight 1-hour ACT sessions over 1 month versus routine SSRI treatment.
- Participants were OCD patients recruited from Tamasha Counseling Center and an obsessive–compulsive clinic in Isfahan, Iran; eligibility was based on DSM-5 criteria, age 18–65, and absence of specified severe comorbidities.
- Outcomes were measured at admission, after treatment, and 3 months later using WHOQOL-BREF and the DASS-42 depression subscale; repeated-measures ANOVA was used for analysis, adjusting for pretest scores and age.
## Limitations
- The paper states that generalization should be cautious because patients came from university-affiliated medical centers and sessions were intensive, so results may not apply to patients from private centers.
- The paper states that outcomes relied on self-report questionnaires, so other assessment methods are needed to determine clinically significant effectiveness.
- Evident from the text: the analyzed sample was small, with 13 ACT and 14 drug participants completing the study, which limits precision and broader inference.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
0 Valid · 0 Not valid · 10 Not checked · 21 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There were no significant differences in QOL scores between the two groups after the intervention and follow-up (P > 0.05).”
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > Abstract > Results:
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Nevertheless, drug therapy presented a significantly greater improvement in depression scores of patients than those resulting from ACT (P = 0.005).”
- Also stated in: § Comparison of two groups · plain
“Moreover, the SSRI treatment had a greater effect on the severity of depressive symptoms than the ACT treatment did (P < 0.05) [Table 2].”
- Also stated in: § DISCUSSION The findings of this study revealed that the two treatments (ACT and SSRIs drug therapy) were effective interventions in reducing depression symptom severity and increasing perceived QOL based on the WHOQOL-BREF total score at posttreatment and follow-up assessments. This finding, which was based on the effectiveness of acceptance and commitment-based therapy, is similar to those of previous studies that revealed the effectiveness of ACT in reducing the symptoms of patients with OCD.[89101112] The findings of this study are consistent with those of Dehlin et al., which confirmed the adequacy of ACT treatment in improving depressive symptoms, QOL, and obsessive–compulsive symptoms in OCD patients.[27] The finding is also consistent with that of Michael et al. (2017), who provided a systematic review of RCTs assessing ACT for depression and anxiety disorders. Their findings revealed that ACT appeared to be more efficacious than waitlist conditions. They showed that ACT therapy outcomes were mediated through increases in psychological flexibility and health behavior.[14] A possible explanation for the effectiveness of ACT could be due to producing greater psychological flexibility by creating a good and acceptable relationship with obsessive thoughts and emotions in OCD patients. Thus, ACT will exacerbate psychological flexibility, which is the ability to act compatible with patient's valued life directions regardless of amiss inner experiences.[89] To support this perspective, evidences[9101112] show that reductions in OCD symptoms are due to the specific processes used in ACT (i.e., acceptance and cognitive diffusion). Our findings also demonstrated that SSRIs, including prescribed fluoxetine, fluvoxamine, and sertraline, were effective in reducing the symptoms of depression and improving the QOL in patients with OCD. These results support the findings of meta-analysis on early onset of response to SSRIs in OCD by Issari et al.[2] This meta-analysis has 17 trials of SSRIs with 3276 OCD patients. Compared to placebo, a statistically significant benefit of SSRIs was observed within 2 weeks after the start of the treatment and a significantly greater response was associated with using higher doses of SSRIs. · plain
“Nevertheless, treatment with SSRIs presented a significantly greater improvement in depression symptoms than those resulting from ACT intervention.”
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > Abstract > Results:
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Comparison of two groups · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The persistence of treatment effects continued after 3 months (follow-up) in both groups.”
- Also stated in: § Follow-up outcomes · plain
“Based on WHOQOL and DASS-42 scores at the follow-up assessment, treatment effects continued after 3 months (follow-up) in both groups.”
- Also stated in: § Follow-up outcomes · plain
“In both groups, the scores of QOL and severity of depression in the follow-up stage were significantly different from the pretreatment stage (P < 0.05).”
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > Abstract > Results:
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Follow-up outcomes · plain
In the paper
“ACT has indicated significant effects on improving OCD symptoms in adults and adolescents.[89101112]”
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > INTRODUCTION While drugs, such as selective serotonin reuptake inhibitors (SSRIs), are being used as the main treatment plan in obsessive–compulsive disorder (OCD), a large number of patients have clinically significant OCD symptoms after these treatments.[1234] The acceptance and commitment therapy (ACT) is one of the newest treatment strategies that has recently been rapidly developed to improve the treatment for patients with OCD.[56] As a third-wave behavior therapy, ACT focuses on reducing experiential avoidance, increasing activity in the chosen valued life direction, and increasing psychological flexibility.[7] According to the ACT theory, patients with OCD attempt to decrease unwanted obsessional thoughts, which often paradoxically increase the frequency or severity of these amiss obsessional thoughts, and thus result in the inability to act in accordance with a patient's valued direction.[8] ACT teaches patients to create a good and acceptable relationship with obsessive thoughts and emotions. Moreover, it helps patients to spend more time on their valued life goals, as well as to accept their obsessional thoughts and negative feelings and commit to act on the way of their valued life directions whether or not obsessions were occurring. Thus, ACT will exacerbate psychological flexibility, which is the ability to act compatible with a patient's valued life directions regardless of amiss inner experiences.[891011] ACT has indicated significant effects on improving OCD symptoms in adults and adolescents.[89101112] Although OCD and depression are two independent disorders, some researches have revealed that patients with OCD often suffer from depression, a comorbidity accompanied with greater symptom severity and suicide risk.[13] A review study with 36 RCTs revealed that ACT seems to be more effective than the waitlist group and those who received other treatment, with largely equivalent effects relative to traditional cognitive–behavioral therapy. Findings demonstrate that ACT treatment outcomes are mediated by a decrease in psychological inflexibility, its theorized process of change.[14] Although cognitive–behavioral therapies were compared with SSRIs in previous studies for the treatment of patients with OCD, there are few studies evaluating the effectiveness of ACT on QOL and the severity of depression symptoms in OCD patients compared with SSRIs. Therefore, this study was designed to investigate the possible effects of ACT on the severity of depression symptoms and QOL in obsessive–compulsive patients.
What the sources say
- Not matchedcites [89101112]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“The psychometric properties of these instruments have been confirmed as acceptable in most of these populations.[21222324] interclass correlation and Cronbach's alpha values of the Persian version was reported more than 0.7 in all areas.”
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > MATERIALS AND METHODS > Instruments
What the sources say
- Not matchedcites [21222324]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
6 more claims
Create a free account to see all 31 claims and every source verdict.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“ACT has been shown to be as effective as drug therapy in improving the quality of life of patients with OCD [42].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > MATERIALS AND METHODS > Participants
“The data of 13 patients in the ACT group and 14 patients in the drug group were analyzed after the intervention and in the follow-up stage.”
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > RESULTS > Demographic characteristics of groups
“The mean age of the patients in ACT intervention group (4 males, 10 females) was 32.71 ± 8.27 years and in drug control group (4 males, 9 females) was 31 ± 7.43 years.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > Abstract > Materials and Methods:
“Selected patients were allocated to two groups (14 in ACT the group and 13 in the drug group”
§ A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder > MATERIALS AND METHODS > Participants
“finally, 30 participants, including 15 in the drug group and 15 people in the ACT, were randomly assigned.”
Citations
Cites
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2012) · International Journal of Surgery · doi:10.1016/j.ijsu.2011.10.001 · Cited by 2,345 · cited 1×
“[16,17] The process of patient allocation and randomization based on CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomized trials[18] were performed as follows.”
MethodFoa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
Abramowitz, J. S., Taylor, S., & McKay, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60240-3 · Cited by 1,002
Random allocation software for parallel group randomized trials
Saghaei, M. (2004) · BMC Medical Research Methodology · doi:10.1186/1471-2288-4-26 · Cited by 793 · cited 1×
“0.[16,17] The process of patient allocation and randomization based on CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomized trials[18] were performed as follows.”
MethodHayes, S. C. (2016) · Behavior Therapy · doi:10.1016/j.beth.2016.11.006 · Cited by 785
Bonomi, A. E., Patrick, D. L., Bushnell, D. M., & Martin, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00123-7 · Cited by 558
Psychological treatment of obsessive–compulsive disorder: A meta-analysis
Rosa-Alcázar, A. I., Sánchez-Meca, J., Gómez-Conesa, A., & Marín-Martínez, F. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2008.07.001 · Cited by 444
Power, M., The World Health Organization Quality of Life Group, Bullinger, M., & Harper, A. (1999) · Health Psychology · doi:10.1037/0278-6133.18.5.495 · Cited by 440
Research works printed but not linked: 2
- Anvari, 2014, The effectiveness of group-based acceptance and commitment therapy on pain-related anxiety, acceptance of pain and pain intensity in patients with chronic pain, J Isfahan Med Sch, 32, 1156
- Nejat, 2006, The World Health Organization Quality of Life questionnaire: Translation and validation study of the Iranian Version, J Sch Public Health Inst Public Health Res, 4, 1
Cited by
Amini, N., Modir, H., Omidvar, S., et al. (2022) · Journal of West African College of Surgeons · doi:10.4103/jwas.jwas_183_22 · Cited by 9
Wang, D., Lin, B., Zhang, S., Xu, W., & Liu, X. (2024) · Journal of Medical Internet Research · doi:10.2196/50664 · Cited by 10
Apolinário-Hagen, J., Drüge, M., Guthardt, L., & Haller, E. (2024) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-97-4402-2_12 · Cited by 6
Ribeiro, R. B., Generoso, M. B., Taiar, I., Lord, A. E. D. C., Netto, G. T. M., Gomes, J. S., Garrocini, L. P., Maranhão, M. F., de Araujo, M. A. A., da Silva, S. M. A. C., et al. (2023) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085000000429 · Cited by 4
Ferraz, D., & Escarião, P. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_39
Metadata
- Authors
- Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B.
- Affiliations
- Isfahan University of Medical Sciences (IR)
- University of Isfahan (IR)
- Kermanshah University of Medical Sciences (IR)
- Corresponding author
- Ebrahimi, Amrollah
- Venue
- Journal of Research in Medical Sciences
- Published
- 2022-01
- Volume
- 27
- Issue
- 1
- Pages
- 9
- ISSN
- 1735-1995 (ISSN-L)
- PMC
- PMC8943588
- OpenAlex
- W4212857057
- Cited by
- 9
- References
- 36
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Journal of Research in Medical Sciences (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- acceptance and commitment therapy, obsessive-compulsive disorder, selective serotonin reuptake inhibitors, depressive symptoms, quality of life, psychotherapy versus pharmacotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder. https://app.cochat.ai/papers/10.4103/jrms.jrms_449_21
- The paper
- Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obsessive–compulsive disorder. Journal of Research in Medical Sciences. https://doi.org/10.4103/jrms.jrms_449_21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.